Logo image of SLS

SELLAS LIFE SCIENCES GROUP I (SLS) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:SLS - US81642T2096 - Common Stock

4.26 USD
-0.25 (-5.54%)
Last: 1/23/2026, 8:00:02 PM
4.28 USD
+0.02 (+0.47%)
After Hours: 1/23/2026, 8:00:02 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to SLS. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 6.97. This target is 63.61% above the current price.
  • SLS was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SLS.
  • In the previous month the buy percentage consensus was at a similar level.
  • SLS was analyzed by 7 analysts. More opinions would make the average more meaningful.
SLS Historical Analyst RatingsSLS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -109 -99 -89 -79 -69 -59 -49 -39 -29 -19 -9 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 4.266.067.146.977.88 - 42.25% 67.61% 63.61% 84.86%
SLS Current Analyst RatingSLS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-07-16 Maxim Group Maintains Buy -> Buy
2023-11-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-07 Cantor Fitzgerald Reiterate Overweight -> Overweight
2022-11-15 Alliance Global Partners Maintains Buy
2022-06-28 Cantor Fitzgerald Maintains Overweight
2021-07-21 Cantor Fitzgerald Initiate Overweight

SELLAS LIFE SCIENCES GROUP I / SLS FAQ

What is the price target for SLS stock?

7 analysts have analysed SLS and the average price target is 6.97 USD. This implies a price increase of 63.61% is expected in the next year compared to the current price of 4.26.


Can you provide the consensus rating for SELLAS LIFE SCIENCES GROUP I stock?

The consensus rating for SELLAS LIFE SCIENCES GROUP I (SLS) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.